INCYTE CORPORATION Restricted Cash and Cash Equivalents, Noncurrent
INCYTE CORPORATION (INCY) had Restricted Cash and Cash Equivalents, Noncurrent of $14.26 million as of 2015-06-30, per its 10-Q filed 2015-08-04.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Investments, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2015-08-04
- 2015-06-30: Restricted Cash and Cash Equivalents, Noncurrent $14.26M.
- 2015-03-31: Restricted Cash and Cash Equivalents, Noncurrent $13.88M.
- 2014-12-31: Restricted Cash and Cash Equivalents, Noncurrent $14.00M.
- 2014-09-30: Restricted Cash and Cash Equivalents, Noncurrent $14.13M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2015-06-30 | $14.26M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $13.88M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $14.00M 10-Q · filed 2015-08-04 |
| 2014-09-30 | $14.13M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $14.25M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $14.38M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $14.50M 10-K · filed 2015-02-17 |
| 2011-09-30 | $9.98M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $9.97M 10-Q · filed 2011-07-28 |
| 2011-03-31 | $18.91M 10-Q · filed 2011-05-03 |
| 2010-12-31 | $18.89M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |